TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 304 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,078,987 | -52.3% | 134,388 | -51.5% | 0.20% | +2.6% |
| Q2 2023 | $4,354,426 | +88.6% | 277,176 | +97.9% | 0.20% | -8.4% |
| Q1 2023 | $2,308,580 | -47.5% | 140,084 | -50.3% | 0.21% | +6.5% |
| Q4 2022 | $4,397,006 | +291.5% | 281,860 | +225.5% | 0.20% | +81.1% |
| Q3 2022 | $1,123,000 | -43.1% | 86,581 | -38.4% | 0.11% | -42.2% |
| Q2 2022 | $1,972,000 | -6.8% | 140,444 | -4.9% | 0.19% | -2.5% |
| Q1 2022 | $2,115,000 | +224.4% | 147,692 | +208.6% | 0.20% | +233.9% |
| Q4 2021 | $652,000 | – | 47,852 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |